Remdesivir and COVID-19 : what are the implications for Africa?
| dc.contributor.author | Green, Robin J. | |
| dc.contributor.author | Mustafa, Fatima | |
| dc.contributor.author | Sewlall, Nivesh | |
| dc.contributor.author | Richards, Guy A. | |
| dc.contributor.email | robin.green@up.ac.za | en_ZA |
| dc.date.accessioned | 2021-03-24T10:12:59Z | |
| dc.date.available | 2021-03-24T10:12:59Z | |
| dc.date.issued | 2020-06 | |
| dc.description.abstract | We feel compelled to point out a few inconsistencies in new reports surfacing to support the use of remdesivir in the COVID-19 crisis. | en_ZA |
| dc.description.department | Paediatrics and Child Health | en_ZA |
| dc.description.librarian | am2021 | en_ZA |
| dc.description.uri | http://www.samj.org.za | en_ZA |
| dc.identifier.citation | Green, R.J., Mustafa, F., Sewlall, N. et al. 2020, ' Remdesivir and COVID-19 : what are the implications for Africa?', South African Medical Journal, vol. 110, no. 6, pp. 447-448. | en_ZA |
| dc.identifier.issn | 0256-9574 (print) | |
| dc.identifier.issn | 2078-5135 (online) | |
| dc.identifier.other | 10.7196/SAMJ.2020. v110i6.14889 | |
| dc.identifier.uri | http://hdl.handle.net/2263/79060 | |
| dc.language.iso | en | en_ZA |
| dc.publisher | Health and Medical Publishing Group | en_ZA |
| dc.rights | © 2019, South African Medical Association. This article is licensed under a Creative Commons Attribution-NonCommercial Works License (CC BY-NC 3.0). | en_ZA |
| dc.subject | Remdesivir | en_ZA |
| dc.subject | Crisis | en_ZA |
| dc.subject | COVID-19 pandemic | en_ZA |
| dc.subject | Coronavirus disease 2019 (COVID-19) | en_ZA |
| dc.subject | South Africa (SA) | en_ZA |
| dc.subject | National Institute of Allergy and Infectious Diseases (NIAID) | en_ZA |
| dc.title | Remdesivir and COVID-19 : what are the implications for Africa? | en_ZA |
| dc.type | Article | en_ZA |